机译:载体CD19嵌合抗原受体改性T细胞长期持久抗CD19活性的证据在我研究靶向小儿毒性白血病
Hebei Med Univ Hosp 2 Dept Pediat Hematol Oncol Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Med Univ Hosp 2 Dept Pediat Hematol Oncol Shijiazhuang Hebei Peoples R China;
Hebei Med Univ Hosp 2 Dept Pediat Hematol Oncol Shijiazhuang Hebei Peoples R China;
Hebei Med Univ Hosp 2 Dept Pediat Hematol Oncol Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
Hebei Med Univ Hosp 2 Dept Hematol Shijiazhuang Hebei Peoples R China;
Hebei Senlang Biotechnol Co Ltd CAR T Res Ctr Shijiazhuang Hebei Peoples R China;
B-ALL; CAR-T; CD19; chimeric antigen receptor;
机译:载体CD19嵌合抗原受体改性T细胞长期持久抗CD19活性的证据在我研究靶向小儿毒性白血病
机译:载体CD19嵌合抗原受体改性T细胞长期持久抗CD19活性的证据在我研究靶向小儿毒性白血病
机译:在I阶段研究靶向儿科的侵袭性CD19嵌合抗原受体改性T细胞的持久抗CD19活性的证据证明靶向小儿毒性淋巴细胞白血病
机译:在长期培养中急性淋巴细胞白血病细胞非周期性振荡中确定性混沌的证据
机译:儿科T细胞急性淋巴细胞白血病中NOTCH1信号传导的分子和治疗意义。
机译:复发/难治性急性淋巴细胞白血病患者CD19单型和CD19 / CD22双特异性嵌合抗原受体T细胞治疗的回顾性比较
机译:复发/难治急性淋巴细胞白血病患者同种异体和自体嵌合抗原受体T细胞疗法的回顾性比较